CompletedNCT01715519
Vilazodone for PTSD and Depression Symptoms
About this title
Vilazodone for the Treatment of Posttraumatic Stress Disorder
Read the official source — NCT01715519Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Long Beach and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 59
- Sponsor
- Southern California Institute for Research and Education
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01715519
- Official title
Show the full official title
A Double-blind, Placebo-controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Long Beach · Omaha
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Southern California Institute for Research and Education, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Treatment (Viibryd).
Who was this study for?
Listed age limits: 18 years to 55 years.
